STOCK TITAN

Liveramp Financials

RAMP
Trailing 12 months to June 30, 2026
Revenue $832.1M +8.9% YoY
Net Income $155.8M +994.2% YoY
EPS (Diluted) $2.42 +952.2% YoY
Free Cash Flow $198.8M +35.9% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD FYE March

Liveramp (RAMP) reported $832.1M in revenue over the twelve months to Jun 30, 2026, up 8.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RAMP FY2026

LiveRamp’s FY2026 profitability inflection is driven by operating-cost leverage and cash conversion, then recycled through share repurchases.

The earnings-to-cash link strengthened: net income reached $146M while operating cash flow was $167.8M, so profitability was accompanied by cash rather than merely accrual earnings. However, a $46.7M tax benefit helped lift net income above operating income of $83.5M, making operating profit the cleaner measure of the underlying inflection.

Gross margin stayed near 71.0% while operating margin reached 10.3%, so the improvement occurred below gross profit rather than through higher gross economics. R&D fell from $176.7M to $148.1M as revenue expanded, pointing to lower development intensity as the main visible operating lever.

Debt-to-equity remained 0.3x as the current ratio declined to 2.5x, indicating a thinner short-term cushion without a debt-heavy posture. Share repurchases reached $194.5M, exceeding free cash flow and showing that shareholder distributions consumed more internally generated cash than reinvestment did.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 62 / 100
Financial Health Score 62/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Liveramp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
44

Liveramp has an operating margin of 10.3%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 44/100, indicating healthy but not exceptional operating efficiency. This is up from 0.7% the prior year.

Growth
67

Liveramp's revenue grew 9.0% year-over-year to $812.9M, a solid pace of expansion. This earns a growth score of 67/100.

Leverage
67

Liveramp carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 67/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
68

With a current ratio of 2.47, Liveramp holds $2.47 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 68/100.

Cash Flow
86

Liveramp converts 20.5% of revenue into free cash flow ($166.4M). This strong cash generation earns a score of 86/100.

Returns
37

Liveramp's ROE of 15.0% shows moderate profitability relative to equity, earning a score of 37/100. This is up from -0.1% the prior year.

Altman Z-Score Safe
7.06

Liveramp scores 7.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.3B) relative to total liabilities ($322.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Liveramp passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.15x

For every $1 of reported earnings, Liveramp generates $1.15 in operating cash flow ($167.8M OCF vs $146.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$812.9M
YoY+9.0%
5Y CAGR+12.9%
10Y CAGR-0.4%

Liveramp generated $812.9M in revenue in fiscal year 2026. This represents an increase of 9.0% from the prior year.

EBITDA
$96.9M
YoY+328.4%
10Y CAGR+3.0%

Liveramp's EBITDA was $96.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 328.4% from the prior year.

Net Income
$146.0M
YoY+14700.0%
10Y CAGR+36.1%

Liveramp reported $146.0M in net income in fiscal year 2026. This represents an increase of 14700.0% from the prior year.

EPS (Diluted)
$2.24

Liveramp earned $2.24 per diluted share (EPS) in fiscal year 2026.

Cash & Balance Sheet

Free Cash Flow
$166.4M
YoY+8.8%
10Y CAGR+9.7%

Liveramp generated $166.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 8.8% from the prior year.

Cash & Debt
$379.5M
YoY-8.2%
5Y CAGR-7.9%
10Y CAGR+7.2%

Liveramp held $379.5M in cash as of fiscal year 2026; long-term debt is not reported for that period.

Shares Outstanding
60M

Liveramp had 60M shares outstanding in fiscal year 2026.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin
70.7%
YoY-0.3pp
5Y CAGR+3.2pp
10Y CAGR+28.2pp

Liveramp's gross margin was 70.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin
10.3%
YoY+9.6pp
5Y CAGR+37.5pp
10Y CAGR+11.8pp

Liveramp's operating margin was 10.3% in fiscal year 2026, reflecting core business profitability. This is up 9.6 percentage points from the prior year.

Net Margin
18.0%
YoY+18.1pp
5Y CAGR+38.3pp
10Y CAGR+17.2pp

Liveramp's net profit margin was 18.0% in fiscal year 2026, showing the share of revenue converted to profit. This is up 18.1 percentage points from the prior year.

Return on Equity
15.0%
YoY+15.1pp
5Y CAGR+23.4pp
10Y CAGR+14.1pp

Liveramp's ROE was 15.0% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 15.1 percentage points from the prior year.

Capital Allocation

R&D Spending
$148.1M
YoY-16.1%
5Y CAGR+1.9%
10Y CAGR+7.2%

Liveramp invested $148.1M in research and development in fiscal year 2026. This represents a decrease of 16.1% from the prior year.

Share Buybacks
$194.5M
YoY+92.2%
5Y CAGR+35.7%
10Y CAGR+13.9%

Liveramp spent $194.5M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 92.2% from the prior year.

Capital Expenditures
$1.4M
YoY+32.1%
5Y CAGR-8.8%
10Y CAGR-29.8%

Liveramp invested $1.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 32.1% from the prior year.

RAMP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RAMP quarterly income statement
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Revenue$214.0M+3.8%$206.1M-2.9%$212.2M+6.2%$199.8M+2.6%$194.8M+3.2%$188.7M-3.4%$195.4M+5.4%$185.5M
Cost of Revenue$63.0M+4.1%$60.5M+1.5%$59.7M+0.1%$59.6M+2.2%$58.3M+0.7%$57.9M+5.3%$55.0M+7.3%$51.2M
Gross Profit$150.9M+3.7%$145.5M-4.6%$152.5M+8.8%$140.2M+2.7%$136.5M+4.4%$130.8M-6.9%$140.4M+4.6%$134.2M
R&D Expenses$37.1M-1.6%$37.8M+11.6%$33.8M-8.5%$37.0M-6.7%$39.6M-13.8%$45.9M+7.5%$42.7M-2.6%$43.9M
SG&A Expenses$35.1M+6.6%$33.0M+13.4%$29.1M-12.3%$33.2M-11.2%$37.3M+16.1%$32.2M+0.6%$32.0M+2.0%$31.4M
Operating Income$20.2M+31.8%$15.3M-61.3%$39.5M+84.5%$21.4M+196.7%$7.2M+162.7%-$11.5M-178.4%$14.7M+96.0%$7.5M
Income Tax$5.7M+111.4%-$50.5M-1766.4%$3.0M+223.7%-$2.4M-176.9%$3.2M+764.5%-$479K-105.2%$9.2M-7.7%$10.0M
Net Income$17.5M-75.3%$71.0M+78.0%$39.9M+45.4%$27.4M+253.9%$7.7M+220.1%-$6.5M-157.6%$11.2M+547.2%$1.7M
EPS (Diluted)$0.28-74.5%$1.10+77.4%$0.62+47.6%$0.42+250.0%$0.12+233.3%-$0.09-152.9%$0.17+466.7%$0.03

Not reported in any period shown, so not listed: Interest Expense.

RAMP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RAMP quarterly balance sheet
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Total Assets$1.3B-1.2%$1.3B+2.0%$1.3B+2.3%$1.2B+0.7%$1.2B-2.2%$1.3B+0.5%$1.3B+4.9%$1.2B
Current Assets$635.7M-2.7%$653.1M-3.9%$679.3M+5.0%$646.7M+2.3%$632.4M-3.6%$656.2M+1.9%$643.8M+10.6%$582.1M
Cash & Equivalents$363.5M-4.2%$379.5M-4.1%$395.9M+7.2%$369.4M+1.6%$363.6M-12.0%$413.3M+9.7%$376.8M+11.2%$338.9M
Accounts Receivable$216.7M+1.8%$213.0M-2.7%$218.8M+0.9%$216.8M-1.4%$219.8M+18.1%$186.2M-11.6%$210.6M+9.6%$192.1M
Goodwill$502.0M0.0%$502.1M0.0%$502.2M0.0%$502.2M0.0%$502.2M+0.1%$501.8M0.0%$501.6M-0.1%$501.9M
Total Liabilities$301.4M-6.5%$322.2M+5.0%$306.9M+3.5%$296.6M+4.3%$284.3M-8.4%$310.5M+5.1%$295.5M+12.4%$262.8M
Current Liabilities$239.2M-9.6%$264.8M+5.9%$250.0M+5.5%$237.0M+6.6%$222.4M-10.2%$247.5M+6.9%$231.6M+16.1%$199.5M
Total Equity$977.4M+0.6%$972.0M+1.0%$962.3M+2.0%$943.8M-0.4%$947.8M-0.1%$948.9M-0.9%$957.7M+2.8%$932.1M
Retained Earnings$1.5B+1.2%$1.5B+5.1%$1.4B+3.0%$1.3B+2.1%$1.3B+0.6%$1.3B-0.5%$1.3B+0.9%$1.3B

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

RAMP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RAMP quarterly cash flow statement
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Operating Cash Flow$17.0M-71.1%$58.9M-12.4%$67.3M+17.2%$57.4M+462.9%-$15.8M-125.3%$62.6M+38.7%$45.1M-18.8%$55.6M
Capital Expenditures$703K+143.3%$289K+78.4%$162K-72.5%$589K+75.3%$336K+14.7%$293K+3.9%$282K+17.0%$241K
Free Cash Flow$16.3M-72.2%$58.6M-12.7%$67.1M+18.1%$56.8M+451.7%-$16.2M-125.9%$62.3M+38.9%$44.8M-19.0%$55.4M
Investing Cash Flow-$703K-297.2%-$177K+93.5%-$2.7M-148.9%-$1.1M-20.0%-$917K-295.1%$470K+137.9%-$1.2M-105.4%$22.8M
Financing Cash Flow-$32.3M+57.5%-$76.1M-99.5%-$38.1M+24.3%-$50.3M-44.7%-$34.8M-32.5%-$26.3M-180.7%-$9.4M+81.5%-$50.6M
Share Buybacks$17.6M-76.8%$75.6M+93.0%$39.2M-21.5%$49.9M+67.0%$29.9M+17.4%$25.4M+152.0%$10.1M-79.8%$49.9M

Not reported in any period shown, so not listed: Dividends Paid.

RAMP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

RAMP quarterly financial ratios
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Gross Margin70.5%-0.1pp70.6%-1.3pp71.9%+1.7pp70.2%+0.1pp70.1%+0.8pp69.3%-2.6pp71.9%-0.5pp72.4%
Operating Margin9.4%+2.0pp7.4%-11.2pp18.6%+7.9pp10.7%+7.0pp3.7%+9.8pp-6.1%-13.6pp7.5%+3.5pp4.0%
Net Margin8.2%-26.2pp34.4%+15.6pp18.8%+5.1pp13.7%+9.7pp4.0%+7.4pp-3.4%-9.2pp5.7%+4.8pp0.9%
Return on Equity1.8%-5.5pp7.3%+3.2pp4.1%+1.2pp2.9%+2.1pp0.8%+1.5pp-0.7%-1.9pp1.2%+1.0pp0.2%
Return on Assets1.4%-4.1pp5.5%+2.3pp3.1%+0.9pp2.2%+1.6pp0.6%+1.1pp-0.5%-1.4pp0.9%+0.8pp0.1%
Current Ratio2.66+0.2x2.47-0.3x2.720.0x2.73-0.1x2.84+0.2x2.65-0.1x2.78-0.1x2.92
Debt-to-Equity0.310.0x0.330.0x0.320.0x0.310.0x0.300.0x0.330.0x0.310.0x0.28
FCF Margin7.6%-20.8pp28.4%-3.2pp31.6%+3.2pp28.4%+36.7pp-8.3%-41.3pp33.0%+10.1pp22.9%-6.9pp29.8%

Similar Companies

Frequently Asked Questions

What is Liveramp's annual revenue?

Liveramp (RAMP) reported $812.9M in total revenue for fiscal year 2026. This represents a 9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Liveramp's revenue growing?

Liveramp (RAMP) revenue grew by 9.0% year-over-year, from $745.6M to $812.9M in fiscal year 2026.

Is Liveramp profitable?

Yes, Liveramp (RAMP) reported a net income of $146.0M in fiscal year 2026, with a net profit margin of 18.0%.

Liveramp (RAMP) reported diluted earnings per share of $2.24 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Liveramp (RAMP) had EBITDA of $96.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Liveramp (RAMP) had a gross margin of 70.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Liveramp (RAMP) had an operating margin of 10.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Liveramp (RAMP) had a net profit margin of 18.0% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Liveramp (RAMP) has a return on equity of 15.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Liveramp (RAMP) generated $166.4M in free cash flow during fiscal year 2026. This represents a 8.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Liveramp (RAMP) generated $167.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Liveramp (RAMP) had $1.3B in total assets as of fiscal year 2026, including both current and long-term assets.

Liveramp (RAMP) invested $1.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Liveramp (RAMP) invested $148.1M in research and development during fiscal year 2026.

Yes, Liveramp (RAMP) spent $194.5M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Liveramp (RAMP) had 60M shares outstanding as of fiscal year 2026.

Liveramp (RAMP) had a current ratio of 2.47 as of fiscal year 2026, which is generally considered healthy.

Liveramp (RAMP) had a debt-to-equity ratio of 0.33 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Liveramp (RAMP) had a return on assets of 11.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Liveramp (RAMP) has an Altman Z-Score of 7.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Liveramp (RAMP) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Liveramp (RAMP) has an earnings quality ratio of 1.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Liveramp (RAMP) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top